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Poster001 
 
The advanced pharmacy practice experience at the 
University of Oslo 
 
Anne RØV-JOHNSEN, Ingunn BJÖRNSDOTTIR 
Background 
The Advanced pharmacy practice experience (APPE) in European 
countries is to a certain extent directed by the EU directive 
requirement of pharmacy students having a 6 months training in a 
community or hospital pharmacy. However, a wide variety has 
been found in how the APPE is structured. Looking outside of the 
EU, the variation becomes even larger, in terms of duration and 
placement of the training. FIP has emerged around the assumption 
that pharmacists worldwide have a certain basis in common. 
Therefore, a description of the organization of APPE in one country 
can be a good basis for discussion APPE in general.  
Purpose 
To describe the APPE at the University of Oslo (UiO) and planned 
changes to the structure and contents in the next 2 years. 
Methods 
The contents of the current and future APPE are described based 
on the course handbook “Pharmaceutical Apprenticeship”, the 
course descriptions for the existing (FRM4000) and future 
(FARM3130) course, material in the course’s web-based learning 
platform and planned changes to the evaluation form.  
Results 
At UiO, the APPE is in the 7th semester of the Master program in 
pharmacy and consists of approximately 21 Weeks in a community 
or hospital pharmacy, with periods of instruction at the University. 
Each student submits a mandatory folder consisting of tasks and 
essays in topics such as prescription evaluation, communication 
and ethics. Examination consists of a 1 hour multiple-choice, and a 
15 minutes oral presentation of prescriptions and other problem-
solving tasks. 
Conclusions 
The APPE at UiO is mainly a training period, with evaluation of 
written tasks. Planned changes include a move to the 6th 
semester, revision of the course contents and changing the 
examination form. 
 
 
Poster003 
 
Daratumumab: multiple myeloma outcomes 
 
João P. RAPOSO, Carla T. BARROS, Filipe CAETANO 
Background 
Multiple myeloma (MM) is an incurable malignancy of plasma cell 
that accounts for 10% of haematological diseases. In Portugal, the 
incidence is estimated in 514 cases per year. In 2016 daratumumab 
was approved in EU in monotherapy. Later, it was also investigated 
the combination of daratumumab with bortezomib or 
lenalidomide. The addition of daratumumab to bortezomib or 
lenalidomide demonstrated a significant reduction in the risk of 
disease progression or death in patients who have at least received 
one prior therapy. 
Purpose 
This study aims to contribute with real-world data on 
daratumumab treatment outcomes, which are scarce. 
Methods 
Retrospective cohort chart review study over a 19-month period 
(July 2016 to January 2018). 
Results  
Thirteen patients with MM were enrolled with a median age of 71 
years (range 60-79) and most of them men (53.8%). The prevalent 
type of MM was IgG (69.2%) and IgA (15.4%). Standard cytogenetic 
risk was observed in 76.9% of the patients and high risk in 23.1%. 
The median previous treatment lines were 2 (range 1-4), including 
Bortezomib (92.3%) and lenalidomide (84.6%).  Five patients were 
treated with daratumumab in monotherapy (38.5%), five (38.5%) 
daratumumab + lenalidomide and 3 (23.1%) daratumumab + 
bortezomib). Four (80%) of five patients that were treated with 
daratumumab in monotherapy have deceased with a median of 
50.5 survival days (range 30-102). By the end of the study all 
patients in combined therapy were alive as well the one that was 
in monotherapy. Across all groups the most common adverse 
events of grade ≥35% were: peripheral neuropathy (61.5%), 
anaemia (46.2%) and equally rhinorrhoea, productive cough and 
peripheral oedema (38.5%).  
Conclusions 
Our study indicates that there is improved patient’s survival 
treated with the combination therapy as demonstrated in the 
POLLUX and CASTOR trials. The safety profile is comparable to 
those of mentioned studies. 
 
 
Poster004 
 
Evaluation of oral production accuracy of 
Portuguese brand names of medicines 
 
Carla PIRES, Susana CORREIA, Márcia COSTA, Afonso M. 
CAVACO, Marina VIGÁRIO 
Background 
Incorrect productions of medicine names may cause medication 
errors. Studies evaluating oral productions of Portuguese brand 
names are scarce, although medicine agencies recommend that 
medicine names are pronounceable. 
Purpose 
To evaluate the influence of the phonological and orthographic 
structure. 
Methods 
Participants: 37 customers of pharmacies (older/less educated: 
58.7 ±12.8 years-old; 7.5 ±3.2 years of schooling) and 30 students 
from a humanities faculty (younger/more educated: 25.9 ±9.3 
years-old; 14 ±1 years of schooling) in the Lisbon area, 2014/15. 
Students were asked to read aloud 12 names (repeated 3 times). 
Pharmacy customers read the 12 names only once, for time 
limitations. Names were classified in three groups: 1) names with 
“y”, “k”, or “w”, letters not belonging to Portuguese native 
vocabulary (e.g. Propycil®), 2) names not written according to the 
Portuguese orthographic rules (e.g. Qutenza®), and 3) names 
complying with Portuguese orthography (e.g. Claritine®). Names 
were sequentially presented in a screen and audio recorded. A 
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trained linguist transcribed/coded 1495 outputs. Only adults 
capable of performing the task were enrolled. Non-parametric Chi-
square (p<0.05) was applied. 
Results 
Overall, less educated have produced significantly more errors 
than more educated ones (X2 = 92.875, p<0.001); 31% vs. 14.4% 
incorrect productions. Percentage of correct productions in 
canonical vs. names with letters “y”, “k”, or “w” vs. non-canonical 
names: more educated (90.3% vs. 82.6% vs. 75.3%), and less 
educated participants (64.6% vs. 68.5% vs. 44.3%). 
Conclusions 
Less educated participants performed worst, suggesting that this 
population might be more vulnerable to medication errors. Brand 
names not complying with regulations requirements seem to 
favour production errors. More investigation is needed towards 
creating linguistic norms to develop/adapt suitable medicine 
names. 
 
 
Poster005 
 
Are Portuguese brand names of medicines 
readable? 
 
Carla PIRES, Susana CORREIA, Afonso M. CAVACO, Marina 
VIGÁRIO 
Background 
Misunderstandings involving medicine names may cause serious 
medication problems. According to regulations, medicines names 
must be readable and pronounceable. However, investigation on 
readability of medicines names is limited. 
Purpose 
To quantify and characterize phonological errors in a reading task 
of Portuguese medicines brand names. 
Methods 
Undergraduates from a Portuguese faculty were conveniently 
selected from non-biomedical courses to minimize prior 
knowledge on names investigated (2014). Overall, 12 names were 
tested repeated 3 times. Thirty participants, above age 18 and able 
to perform the task, read aloud names successively displayed on a 
screen. Productions were audiorecorded. 1081 names were 
produced and phonetically transcribed by a trained phonetician, 
who also identified and coded the errors as: substitutions - a 
segment is replaced by another (clarotine for claritine®); insertion - 
a segment is added (claritines for claritine®); metathesis - 
segments interchange positions (cliratine for claritine®); deletion - 
a segment is deleted (claritin for claritine®); inadequate vowel 
reduction. Hesitations and/or lengthening were also coded.  
Results 
Of 1081 names transcribed, 83.3% were fully correct, 10.6% 
contained errors, 5% were produced with hesitations and/or 
lengthening, and 1.1% were not analyzed due to audio problems. 
In the names containing errors (n=114), 187 errors were identified: 
44.4% had deletion errors, 29.4% had substitution errors, 13.9% 
had incorrect insertions, 10.7% had metathesis, and 1.6% were 
produced with incorrect vowel reduction. 
Conclusions 
Brand names of Portuguese medicines are prone to pronunciation 
errors even for educated users. Adaptation to Portuguese grapho- 
and phonotactics might be needed, as recommended in national 
and international regulations. More studies are necessary to 
investigate the potential impact of the different types of errors in 
medication errors, and error type in other social groups (e.g. older, 
less educated subjects; health professionals). 
 
 
Poster006 
 
Conceptual approaches to the sustainability of 
healthcare services and their application to 
pharmacy 
 
Carmen Crespo-Gonzalez.  Victoria Garcia-Cardenas.  
Shalom I. Benrimoj 
Background 
Implementation research aims to develop methodologies to 
incorporate evidence-based innovations into practice. Following 
implementation, accomplishing sustainability of the innovation is 
critically essential to ensure the long-term continuity of services. A 
number of conceptual approaches to the sustainability of 
evidence-based innovations in healthcare exist. These approaches 
aim to guide the process, determine factors influencing and form 
part of the evaluation. However, the sustainability of innovations 
in pharmacy services is an area yet to be studied. Therefore there 
is a need for a conceptual framework to underpin the development 
of sustainable professional pharmacy services. 
Purpose  
To evaluate the conceptual approaches for the sustainability of 
innovations in healthcare in order to develop a framework specific 
for professional pharmacy services.  
Methods 
A systematic literature search was undertaken in February 2018 in 
PubMed, Scopus and Web of Science to identify conceptual 
approaches/theoretical frameworks for the sustainability of 
healthcare innovations. All the titles and abstracts were screened 
and potential articles identified. A table was created for data 
extraction (type and characteristics of conceptual approach, 
innovation used, setting, target user). 
Results 
From the 3033 articles screened, 2585 articles were eliminated 
after title and abstract screening. 448 full-text articles were 
reviewed providing 68 sustainability conceptual approaches. The 
proposed framework for pharmacy services includes two major 
components: the service and the context domains with factors 
which moderate the sustainability of the pharmacy service (e.g. 
adaptability, funding, leadership, and training). The context 
domains include Individuals (e.g. pharmacy staff), Pharmacy, Local 
setting (e.g. healthcare professional, stakeholder) and System. 
Continued evaluations of the service components delivery are 
crucial to prove sustainable service effectiveness.  
Conclusions 
Monitoring the service progress is essential to identify the factors 
affecting its sustainability, allowing their adaptation to the change 
in circumstances. The proposed framework will guide pharmacy 
practice researchers and practitioners to evaluate the 
sustainability of professional services previously implemented. 
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Poster007 
 
Oral anticoagulant therapy with warfarin education 
of hospitalized patients: evaluation of prior 
knowledge and related variables 
 
Cristina R. SIMONI, Caroline TORTATO, Vanelise ZÓRTEA, 
Daniel M. SILVA, Cristina J. DOBLER, Bruno S. ROCHA, 
Diogo PILGER, Luiza F. FLORES 
Background 
Oral anticoagulants (OA) are widely used to prevent and treat 
thromboembolic events, with vitamin K antagonists, such as 
warfarin. It has been shown in recent studies that patients' 
understanding of anticoagulant therapy is of fundamental 
importance for safety and effectiveness. 
Purpose 
The purpose was to quantify the patients with prior knowledge 
about the use of OA therapy, to verify the association between 
prior drug use knowledge and the variables gender, age, indication 
of use and use prior to hospitalization. 
Methods 
A cross-sectional study was carried out in which the profile and 
prior knowledge about the use of OA of patients admitted to the 
Hospital de Clínicas de Porto Alegre using warfarin in the period 
from January 2014 to March 2017. 
Results 
Of the 1635 patients taking warfarin, 50.8% were men, the mean 
age observed was 59.52, and 51.4% used this medication prior the 
hospitalization. There was no statistically significant difference in 
the type and time of counseling performed by the pharmacist in 
the different genders. Regarding previous knowledge about the 
therapy, it is possible to infer that men knew more about the 
frequency/dose of medication  (68.6%), time and what to do in 
case of forgetfulness (45.8%) and (54.4%), with a significant 
difference for these data (p <0.05). 
Conclusions 
Knowing the prior knowledge profile and its related variables in the 
performance and pharmaceutical counseling is relevant for the 
elaboration of education strategies that improve the safety and 
the quality of life of the patient before the treatment with OA. 
Studies comparing patient knowledge before and after 
pharmaceutical counseling are necessary to evaluate the 
effectiveness of the education performed, and also important for 
improving orientation strategies. 
 
 
Poster009 
 
Drug-nutrient interactions in medically-complex 
older adults: the need for interdisciplinary 
collaboration 
 
Katherine  L. FORD, Susan J. WHITING, Eric L. LANDRY, 
Derek J. JORGENSON 
Background 
The combined use of prescription and non-prescription 
medications with vitamin and mineral supplements (VMS) poses 
risk for adverse drug-nutrient interactions. A review of the 
literature indicated limited data on the extent to which these 
interactions may be negatively affecting patients and the role that 
pharmacists should play to mitigate the interactions. 
Purpose 
The purpose of this study was to assess the potential for adverse 
drug-nutrient interactions in older adults with complex medication 
use and to determine if there is a need for interventions to ensure 
the safe combined usage of medications and VMS.  
Methods 
A retrospective chart review was completed on 229 medically-
complex patients 50 years of age and older who had new 
assessments of medications completed between January 2014 and 
January 19th, 2017 at the University of Saskatchewan Medication 
Assessment Centre (Canada). Data on medication and VMS use 
was extracted from the medical records. The potential for drug-
nutrient interactions was investigated through four case studies, 
chosen based on the top drug users.  
Results 
Data indicate that 76.9% (n=176) of patients reported using ≥1 
VMS daily. Total product count ranged from 1-45 per day, with a 
mean 9.8 and median of 9. Each case study indicated risk for 
nutrient malabsorption from drug-nutrient interactions. Proton 
Pump Inhibitors were most commonly observed and can cause 
impairment of 6 nutrients when used long term.  
Conclusions 
Concomitant use of medications and VMS was common, with 
many potential drug-nutrient interactions noted. The development 
of practice support tools and education for pharmacists would aid 
in identifying the riskiest and most common drug-nutrient 
interactions. This study highlights the need for improved 
interdisciplinary collaboration between pharmacists and dietitians 
since VMS use was so common in these medically complex 
patients. 
 
 
Poster010 
 
Evaluation of student learning outcomes at an 
internal medicine pharmacist clinic in Canada 
 
Eric L. LANDRY, Katherine LYSAK, Derek J. JORGENSON 
Background 
The creation of a referral-based system of pharmacist specialists 
could be useful in assisting community and hospital pharmacists to 
manage highly complex patients. The University of Saskatchewan 
College of Pharmacy and Nutrition recently opened the Medication 
Assessment Centre (MAC), which accepts complex general 
medicine referrals from any health professional and which 
considers itself an internal medicine pharmacist specialist clinic. 
The MAC is also used as an experiential learning rotation for 
students in the undergraduate pharmacy program. This internal 
medicine pharmacist clinic model has not been previously 
evaluated.  
Purpose 
To evaluate the impact on learning outcomes of pharmacy 
students who participate in experiential education rotations at the 
MAC, which is a referral-based internal medicine pharmacist 
specialist clinic.  
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Methods 
Web-based survey administered to all pharmacy students enrolled 
in any year of the pharmacy program during the 2016-17 academic 
year. The 38-item questionnaire included both Likert-scale and 
free-text questions.  
Results 
Overall response rate 72% (n=250/349). Of the 250 respondents, 
82 (33%) had participated at the MAC at least once. A majority of 
students agreed or strongly agreed that participation at the MAC 
improved: ability to identify drug therapy problems (68%), 
interview skills (75%), therapeutic knowledge (84%), and 
understanding of a pharmacist’s role (89%).  Many respondents 
(79%) felt that the MAC provided skills and knowledge not 
otherwise learned in class (e.g., empathy, compassion, 
communication, prioritization of patient issues, and critical 
thinking). In addition, 93% of student volunteers felt confident in 
their ability to apply the knowledge and skills gained at the MAC. 
Conclusions 
Pharmacy students who participated at the MAC perceived the 
experience had a positive impact on knowledge and skills. Future 
studies should assess if this internal medicine pharmacist clinic 
model has an impact on patient care outcomes and 
community/hospital pharmacist workflow. 
 
 
Poster011 
 
Optimizing care for pediatric eczema patients in 
primary care 
 
Ellen S. KOSTER, Daphne PHILBERT, Marcel L. BOUVY 
Background 
Atopic dermatitis (AD) affects 10-20% of the children worldwide. 
The cornerstone is keeping the skin soft by using emollients and 
topical corticosteroids are used during exacerbations to reduce 
inflammation. Several factors leading to poor adherence and 
resulting in reduced treatment efficacy have been described, e.g. 
lack of knowledge, steroid phobia, misinformation or by pharmacy 
staff.  
Purpose 
Our aim is to improve treatment for children with AD. To achieve 
this we will (1) implement a newly developed intervention for 
pharmacy staff to improve knowledge and patient-centered 
communication and (2) test intervention effectiveness in improving 
medication use and clinical outcomes in patients.   
Methods 
Based on data collected during the first phase – telephone 
interviews with 29 parents of a child with AD and 18 pharmacy 
staff members – an intervention toolbox was developed. The 
toolbox includes a knowledge test for pharmacy staff, information 
about eczema and treatment and patient education materials.  
Results 
Results from study phase 1 showed that many parents mentioned 
fear of steroid adverse effects, with intentional non-adherence as a 
consequence. Both pharmacists and pharmacy technicians 
themselves mentioned that technicians often lack knowledge to 
support patients optimally in correct medication use. Currently, 
the intervention is implemented in 10 Dutch community 
pharmacies. First results from the intervention study will be 
available at time of the conference.  
Conclusions 
Patient counseling is a key aspect for optimizing treatment. 
Pharmacy staff should have sufficient knowledge on treatment and 
their own perceptions about prescribed medicines should not 
influence patient counseling. After completion of the project, we 
expect more knowledge about the treatment of AD in patients and 
caregivers. This project will therefore contribute to improving care 
for young patients. Materials will be made available free of charge 
afterwards. 
 
 
Poster012 
 
Comparing the efficacy of intervention strategies to 
enhance medication adherence: a network meta-
analysis 
 
Elyssa WIECEK, Shalom I. BENRIMOJ, Fernando 
FERNANDEZ-LLIMOS, Fernanda S. TONIN, Andrea TORRES 
ROBLES, Victoria GARCIA-CARDENAS 
Background 
Extensive efforts in the literature have been reported to enhance 
patients’ medication adherence with a wide variety of 
interventions tested in a diversity of settings, clinical conditions, 
populations, and adherence measures.  
Purpose 
The objective of this study was to determine the comparative 
effectiveness of interventions aimed at enhancing medication 
adherence. 
Methods 
A PubMed search was conducted in November 2017 for meta-
analyses analysing adherence interventions. Primary studies from 
these meta-analyses were identified. Experimental studies that 
assessed an intervention to improve adherence in adult patients 
and reported adherence outcomes using any adherence measure 
were included. Data was extracted for study characteristics, 
interventions, and adherence outcomes. Interventions were 
categorized into four groups or combinations: educational, 
attitudinal, technical, and economic.  Network meta-analysis was 
performed to allow estimates for all possible comparisons of 
interventions using direct and indirect evidence. Four networks 
were created based on follow-up time of adherence measurement. 
Results 
Data was obtained from 61 meta-analyses and 438 primary studies 
with 234 studies being included in the network meta-analyses. 
Significant improvement of adherence compared to standard care 
at follow-ups greater than 10 months (n=89) was found for 
economic combined with technical (odds ratio [OR] 0.03, credible 
interval [CrI] 0.01-0.14), educational combined with attitudinal and 
technical (0.44, 0.20-0.98), educational combined with technical 
(0.56, 0.43-0.73), educational (0.57, 0.43-0.75), technical (0.60, 
0.46-0.77), and attitudinal interventions (0.61, 0.41-0.90). 
Economic combined with technical was most effective compared 
to all interventions, though it is critical to acknowledge only one 
study accounted for this strategy with a 60% increase in adherence 
rates among heroin and crack cocaine users. No compelling 
evidence distinguished other long-term intervention strategies. 
Conclusions 
Several interventions can improve adherence while economic 
combined with technical interventions and complex interventions 
demonstrated superior long-term efficacy. Effective interventions 
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should be further tested across other populations and settings to 
determine their full potential. 
 
 
Poster013 
 
Generating real-world evidence related to pharmacy 
interventions – is it possible? 
 
Ema PAULINO, Joana BRITO, Sofia MAXIMIANO, Maria J. 
MENDES, Ana L. PINTO, Patrícia SOARES, Mariana ROSA  
Background 
Pharmacy practice research has been described by the King’s Fund 
as “research which attempts to inform and understand pharmacy 
and the way in which it is practised, in order to support the 
objectives of pharmacy practice and to ensure that pharmacists’ 
knowledge and skills are used to best effect in solving the 
problems of the health service and meeting the health needs of 
the population”. However, research has been mostly conducted in 
time-limited studies that aim to assess a specific service 
implementation and its determinants and/or outcomes. A group of 
400 pharmacies in Portugal has developed a framework to support 
the implementation and documentation of several pharmacy-
based services on an ongoing basis, as a means to generate 
continued real-world evidence on their impact and persistence. 
Purpose  
To describe the development, inception and roll-out of a service 
implementation framework that aims to enact pharmacy services 
in pharmacies. 
Methods 
Descriptive study. Manuals, guides, formularies, and nationally-
validated assessment tools were consolidated in a service 
implementation framework based on the patient pathway, and 
made available to pharmacies. Data from service and project 
implementation, as well as individual patient interactions is 
collected using GoogleForms®. A team of pharmacists provides 
training and ongoing consultancy to pharmacy team members.  
Results 
Since 2013, 72 posters were presented in national and 
international conferences either by the pharmacy group or 
individual pharmacies belonging to the group. Data has been 
presented grouped by disease areas and/or type of service. Data 
monitoring over time has shown that documentation of services 
decreases if pharmacy teams are not stimulated. 
Conclusions 
It is possible to conduct research on an ongoing basis in 
community pharmacies. Better tools for data collection and 
assessment need to be developed in order to increase evidence 
generation efficiency. 
 
 
Poster014 
 
Pharmacist role stress and strain: a scoping review 
 
Faith YONG, Victoria GARCIA-CARDENAS, Shalom I. 
BENRIMOJ 
Background 
Pharmacists are often a point of care in primary healthcare 
systems, and governments are increasingly looking to the 
community pharmacy sector to provide public health functions. 
The effects of this changing role may have an effect on pharmacist 
workload, job dissatisfaction and work stress. Role stress causes 
subjective individual role strain, which are social, psychological and 
physiological responses to the individual role occupant. Pharmacist 
role stress has been implicated in poor pharmacist retention, 
negatively affecting organisational missions and visions and career 
commitment. 
Purpose 
To identify the factors that affect community pharmacist role 
stresses and strains.  
Methods 
The following databases were searched: PubMed, Scopus and Web 
of Science. Inclusion criteria were: English language only, published 
between 1990 and 2018, community pharmacists, role stress and 
role strain.   
Results 
The search strategy identified 4768 articles, with 105 items 
included in the review. Preliminary results produced 45 factors 
affecting role stress categorised in five major categories: 
Interpersonal Interactions (11 factors), Social Setting (16 factors), 
Individual Attributes (15 factors), and Extra-Role (3 factors).  The 
most frequent role stress factors were pharmacist-patient 
interactions, pharmacy environment and workload. There are 9 
factors relating to role strain. The most frequent reported role 
strain factors were Job Satisfaction/Dissatisfaction and Role 
Overload.  
Conclusions 
The application of these findings may improve the working 
conditions and role expectations of pharmacists in modern 
pharmacies which provide cognitive pharmacy services. The results 
suggest that the community pharmacy setting is a complex 
environment that influences pharmacist work behaviour strongly, 
and interactions with many role partners need to be considered. 
Pharmacists also have individual attributes that affect their 
experience of role stress. 
 
 
Poster015 
 
Mapping pharmacy journals through lexicographic 
analysis of article titles 
 
Antonio M. MENDES, Fernanda S. TONIN, Roberto 
PONTAROLO, Fernando FERNANDEZ-LLIMOS 
Background 
Pharmacy, as an area of knowledge, encompasses both 
technological, analytical and care components, which challenge 
categorizing it as a single Subject Area. 
Purpose 
To map the available pharmacy journals as regards their scope. 
Methods 
Journals publishing in English with titles comprising one pharmacy-
related term (i.e., “pharmacy”, “pharmacist*”, “pharmaceuti*”, 
“pharmacol*”, “pharamacotherap*”) were identified in four 
electronic databases (i.e. National Library of Medicine Catalog; 
PubMed Central Journal list; Scopus CiteScore Metrics; and Journal 
of Citation Reports. The titles of all articles (published between 
2006-2016) were extracted and gathered in a single textual corpus. 
The following analyses were performed (Iramuteq 0.7 alpha 2): 
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lexicographic analysis to determine the text segments (ST) and 
frequency of words; descending hierarchical classification (DHC) to 
categorize words and journals with similar lexical groups; and 
factorial correspondence analyses (FCA) to obtain bidimensional 
graphs.  
Results 
A total of 285 journals were identified. In the lexicographic 
analysis, 316,089 article titles were analyzed with a satisfactory 
performance. The DHC generated a dendrogram with six distinct 
lexical classes. The classes were separated into three main 
branches: sub-corpus A (classes 2 and 6); sub-corpus B1 (classes 1 
and 5); and sub-corpus B2 (classes 3 and 4). The most 
representative words and journals for each class were: cell, 
apoptosis, expression (p<0.0001) – Class 2; receptor, channel, rat 
(p<0.0001) – Class 6; patient, trial, treatment (p<0.0001) – Class 1; 
pharmacy, pharmacist, care (p<0.0001) – Class 5; delivery, 
formulation, release (p<0.0001) – Class 3; and determination, 
HPLC, chromatography (p<0.0001) – Class 4.  The two Cartesian 
planes (words and journals) obtained in the FCA showed a clear 
separation between sub-corpuses A and B, but without clear 
distinction between the classes of the same sub-corpus.  
Conclusions 
Through an objective method of textual analysis of articles’ titles, 
we could classify pharmacy journals into three major sub-corpuses 
with six sub-areas: 2 - Cell Pharmacology; 6 – Molecular 
Pharmacology; 1 – Clinical Pharmacology; 5 – Pharmacy Practice; 3 
- Pharmaceutics; and 4 – Pharmaceutical analysis. 
 
 
Poster019 
 
Pharmacist-led medication review with follow-up on 
primary care cardiovascular older adult patients 
(POLARIS) 
 
Francisco MARTÍNEZ MARDONES, Antonio AHUMADA, 
Victoria GARCIA-CARDENAS, Shalom I. BENRIMOJ, Cristian 
PLAZA-PLAZA 
Background 
A pilot study of the impact of pharmacist-led medication reviews 
with follow-up was conducted for three months in 2017 with 66 
patients in eight primary care centers, based on the results 
reported by the conSIGUE study. We found a general trend to 
improve clinical parameters and reduce the number of 
medications. A larger study would allow assessing additional 
outcomes like changes in quality of life and cost-effectiveness of 
the service.  
Purpose 
To assess the impact of a pharmacist-led medication review with 
follow-up in primary care in clinical outcomes, health-related 
quality of life and economic outcomes. 
Methods 
A cluster randomized controlled trial will be held for 12 months in 
primary care centers of the public health system of Chile. We will 
include patients older than 65 years and with more than five 
chronic medications. The intervention arm will receive medication 
review with follow-up. Control group will receive usual care. 
Participating pharmacist will be trained in cardiovascular 
prevention pharmacotherapy in the elderly, interviewing skills and 
educational methods. A practice change facilitator will assist the 
pharmacist in any matters regarding the methodology and will 
assess barriers and facilitators to the implementation of the 
service. A personalized plan will be developed for every 
pharmacist. Primary outcomes will be the rate of controlled health 
problems, changes in health-related quality of life and a cost-utility 
analysis.  Secondary outcomes such as blood pressure, glycated 
hemoglobin, lipid profile, overall cardiovascular disease risk, 
number of medications and adherence will be assessed as well. 
Results 
Recruiting of patients finalized with 746 participants in 22 primary 
care centers, and 295 of them have received at least two 
interviews.  
Conclusions 
This study will allow assessing the impact of pharmacist-led 
medication review with follow-up on cardiovascular older patients 
in Chile. 
 
 
Poster020 
 
A case study of stakeholder experiences and views 
of a novel electronic Monitored Dosage System: 
Biodose Connect 
 
Funmi AGBESANWA, Simon BISHOP, Matthew J. BOYD 
Background  
Monitored Dosage Systems (MDS) have been widely utilised to 
encourage medicines adherence. Electronic MDS (eMDS) have 
additional features such as audio-visual reminders and real-time 
monitoring for added support. Little evidence exists on the impact 
of such devices within distinct patient groups and services. Biodose 
Connect™ is a novel eMDS providing prompts and remote 
monitoring; it can also hold both liquid and solid oral dosage 
forms. The purpose of this study was to explore the views and 
experiences of stakeholders within an assisted-living setting 
piloting this novel eMDS, and to identify its impact on them. 
Methods 
Ten semi-structured interviews prior to eMDS implementation and 
four semi-structured interviews post-implementation were 
conducted. Interviews were completed with the site manager, 
team leaders, assistants and the community pharmacist. Non-
participant observations were completed with four service users 
over two days, recording the activities and behaviours of users 
with the device through field notes. This site provided care-at-
home services including medication support for service users of 
varying needs. Data were audio-recorded, transcribed verbatim 
and thematically analysed. Observational data was thematically 
analysed. 
Results 
Stakeholders were enthusiastic about eMDS implementation and 
its potential change the management of medication. Committed 
proactive teamwork, communication and collaborative working 
provided positive experiences during implementation. 
Implementation process issues at the start of the pilot around 
eMDS set up meant that devices were not used efficiently, 
reducing the effectiveness of the device prompting and alerts. The 
eMDS also seemed more suitable with service users who had lower 
support needs. Many team members stated that the device made 
administration of medicines by care staff easier. 
Conclusion 
Overall stakeholders remain optimistic throughout the pilot of the 
eMDS. Emerging themes suggest that there may be particular 
individuals more suited to such technology. Planned future work 
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includes further follow up interviews at site and review of the 
eMDS adherence data. 
 
 
Poster021 
 
What is the motivation of clinical pharmacists in 
general practice? 
 
Hannah BOWN 
Background 
An ageing population and austerity changes mean that demand in 
general practice is increasing. However, between 2013 and 2014 
GP training applications fell by 15%- supply is therefore not 
meeting demand. In response to this, NHS England rolled out the 
National Pilot for Clinical Pharmacists working in General Practice 
(CPGPs). Affording to the success of the pilot, an additional 1500 
CPGPs are to be employed by 2020/21. 
Purpose 
Up to yet there has been little research into the motivations of 
pharmacists, and no research specifically exploring the motivations 
of CPGPs. The overarching aim of this study was to explore the 
motivations of CPGPs.  
Methods 
Individual semi-structured telephone interviews were conducted 
with thirteen CPGPs and were audio-recorded and transcribed 
verbatim. Three researchers thematically analysed the transcripts 
using the One Sheet of Paper technique, comparing findings 
throughout. 
Results 
Analysis uncovered three overarching themes: Pre-, Present- and 
Post-Motivation. These themes described how the CPGPs 
motivation changed with time in the role. Underpinning these 
themes were seven subthemes: patient-facing, characteristics, 
motivation to change, daily motivation, meeting expectations, 
relationships and later expectations. 
Conclusions 
CPGPs are highly motivated and greatly enjoy the role in general 
practice, with aspirations to develop it in the future. This study 
informs NHS England of the motivations of CPGPs, which could 
lead to a review of the role in which aspects that motivate 
pharmacists are strengthened. It is hoped that this work will 
stimulate further research into the motivation of pharmacists in 
general, but especially in primary care where the role of the 
pharmacist is expanding. Further research should also focus on 
pharmacists who take on this role in the future, to assess whether 
levels of motivation remain the same as those seen in this study." 
 
 
Poster022 
 
Outcomes of diabetes management by pharmacists: 
The RxING practice tool 
 
Hiroshi OKADA, Yazid N. AL HAMARNEH, Ross T. TSUYUKI 
Background 
Optimal community-based care for patients with diabetes remains 
elusive. Pharmacists are highly accessible primary care providers 
who have a strong interest in diabetes management.  
Purpose 
To evaluate the effect of pharmacist management on uncontrolled 
risk factors (poor glycemic control, uncontrolled blood pressure or 
cholesterol, or current smoking) in patients with diabetes.  
Methods 
RxING is a prospective registry used by pharmacists in primary care 
in Alberta. Patients with diabetes must have at least one 
uncontrolled risk factor to be eligible (poor glycemic control, 
uncontrolled blood pressure or cholesterol, or current smoking). 
Pharmacists practice to their full scope, which may include making 
recommendations to the physician, prescribing, adapting 
prescriptions and assessing adherence. Primary outcome is change 
in estimated CV risk. Secondary outcomes are change in HbA1c, 
blood pressure, LDL-cholesterol, tobacco use, and vaccination 
status. 
Results 
This preliminary analysis includes the first 63 patients enrolled by 
21 pharmacists. Sixty one percent of patients were male and 
average age was 58 years. All patients have type 2 diabetes. CV risk 
was reduced from 24.7% to 20.0% after 3 months (p=0.633). 
HbA1c was reduced from 8.5% to 7.6%, BP was reduced from 
139/84 mmHg to 132/80 mmHg, LDL cholesterol was reduced from 
1.87 mmol/L to 1.46mmol/L and smoking was from 13% to 12%. 
Conclusions 
RxING is a practice and implementation tool which helps 
pharmacists systematically evaluate and document their 
interventions in patients with diabetes. With widespread use, this 
can help with practice change and also provide real-world evidence 
for pharmacist care. 
 
 
Poster023 
 
The PharmD controversy: pharmacy undergraduate 
programme change in the context of a developing 
country 
 
Ifunanya IKHILE, Claire ANDERSON, Simon MCGRATH, 
Stephanie BRIDGES 
Background 
The switch from B.Pharm to PharmD undergraduate pharmacy 
programmes in low and middle income countries is a widely 
contested issue in pharmacy education literature1. However, little 
research has been carried out on the motivation for implementing 
this switch in these countries2.  
Purpose 
This research aims to describe motivators, barriers, and facilitators 
to the implementation of the PharmD switch in the context of a 
developing country, using qualitative research methodology.  
Methods 
Qualitative data was taken from a larger study focused on 
developing a tool for the assessment of education relevance to 
practice. 25 semi-structured in-depth individual and group 
interviews were conducted with pharmacy education/practice 
stakeholders in Nigeria across the six geopolitical zones, audio 
recorded and transcribed. Transcripts were analysed thematically 
and specific motivators, facilitators and barriers identified. 
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Results 
Identified motivators include keeping up with global trends, 
pharmacists’ increasing clinical role, and a quest to contribute 
meaningfully to the health team, facilitators include an already 
existent model school, collaboration from foreign experts, 
perceived need for pharmacist’s clinical role, students’ enthusiasm, 
the doctor title while barriers include lack of clinical expertise and 
placement sites, funding, an already overloaded curriculum, 
resistance from medical practitioners. 
Conclusions 
This study found that the major motivator for the switch was to 
keep up with global trends around a patient-focused practice while 
lack of clinical expertise and placement sites were most frequently 
mentioned barriers similar to previous studies3, 4. Despite 
inherent weaknesses of this study such as non-generalizability, 
identified motivators, facilitators and barriers could be useful for 
developing countries that are planning to make the same switch, 
future work may include assessment of the impact of this switch 
on practice. 
 
 
Poster024 
Development of a checklist for community 
pharmacies to facilitate the identification of DRPs 
and improve patient counselling at hospital 
discharge – a study design 
 
Tamara L. IMFELD-ISENEGGER, Helene M. STUDER, 
Markus L. LAMPERT, Kurt E. HERSBERGER 
Background 
After hospital discharge, problems with continuity of care 
(medication discrepancies, administrative problems and the 
necessity for further education) are frequent in community 
pharmacies.  A large number of DRPs might be disclosed with a 
systematic pharmacist-led medication review (MR).  Existing 
checklists and tools for identification of DRPs in community 
pharmacies are designed for use in a clinical MR. However, 
community pharmacies often have no access to clinical data and 
their MR is limited to a type 2a MR according to the PCNE 
classification. 
Purpose 
Development of a checklist for community pharmacies having no 
access to clinical data to facilitate the identification of DRPs and 
improve the counselling of hospital discharged patients. 
Methods 
Clinical pharmacists working in a Swiss hospital pharmacy 
(cantonal hospital of Zug) with an associated community pharmacy 
counselled patients at hospital discharge and documented all 
causes of their interventions in a database (June 2016 – April 
2018). In a first step, an in-depth analysis of the frequency and 
characteristics of the documented DRPs will be conducted. 
Moreover the patients’ demographic data and drugs linked to the 
DRPs will be analysed and correlated with the cause of the 
interventions. Afterwards an expert panel of clinical pharmacists 
and community pharmacists will evaluate those issues causing 
these DRPs that are identifiable by the community pharmacy 
without any access to clinical data (laboratory test results and 
diagnosis). In a third step, the identified issues will be used to 
develop a checklist for the community pharmacy to facilitate the 
identification of DRP and improve patient counselling at hospital 
discharge.  
Conclusions 
Further validation steps will be needed until this checklist will be 
part of a tool kit for community pharmacies counselling patients at 
hospital discharge. 
 
 
Poster026 
 
Coverage of the Global Competency Framework by 
the Spanish Competency Framework 
 
Inês NUNES-DA-CUNHA, Fernando FERNANDEZ-LLIMOS 
Background 
The Global Competency Framework (GCF) from the International 
Pharmaceutical Federation (FIP) was created with the aim of 
supporting the educational development of pharmacy 
practitioners. In Spain, the competencies that qualify pharmacists 
for the practice of the profession are established in the 
CIN/2137/2008 Ministerial order. 
Purpose 
This work aims to compare the Spanish Competency Framework 
(SCF) with the GCF, regard to the competencies that a graduate 
must achieve for a patient-centred practice. 
Methods 
Evaluation of the GCF coverage by the SCF. A pairing between the 
two competencies frameworks was made by consensus among the 
authors. The coverage of the items was differentiated into highly 
covered items and partially covered items. 
Results 
In the FIP framework, 100 competencies are described using 
behavioural terminology, categorized into four main domains: 
“Pharmaceutical Public Health”, “Pharmaceutical Care”, 
“Organisation and Management” and “Professional/Personal”. The 
SCF defined that students must acquire at least 67 specific 
competencies. This study shows that 28 behaviours of the GCF are 
being covered within the SCF. The “Pharmaceutical Public Health 
Competencies” domain is covered in 100%, with 75% of the items 
classified as highly covered and 25% as partially covered items; the 
“Pharmaceutical Care Competencies” domain is covered in 28%, 
with 57,1% of the items classified as highly covered and 42,9% as 
partially covered items; the “Organisation and Management 
Competencies” domain is covered in 25%, with 37,5% of the items 
classified as highly covered and 62,5% as partially covered items; 
and the “Professional/Personal Competencies” domain is covered 
in 23,1%, with 33,3% of the items classified as highly covered and 
66,7% as partially covered items. In the SCF there are two specific 
competencies related to pharmaceutical care that, given its broad 
scope, we have not been able to pair with the competencies 
defined in the GCF. 
Conclusion 
There is still room for improvement in SCF regarding the 
compliance of GCF. 
 
 
Poster027 
Interviews about the advanced pharmacy practice 
experience (APPE) at the University of Oslo 
 
Ingunn BJÖRNSDÓTTIR, Naila ALI, Nada R. ISMAIL,  
Anne RØV-JOHNSEN 
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Background 
The length of the Advanced pharmacy practice experience (APPE) 
in European countries is decided by the 6 months EU directive 
requirement, that also specifies community pharmacy training, 
alternatively hospital pharmacy supervised training.  This gives 
considerable flexibility in structure and content. Looking outside of 
the EU, the variation becomes even larger, as some countries 
require less than 6 months, some more, and some do not tie the 
training period to a pharmacy. Since FIP is based on pharmacists 
having a common ground, pharmacists might benefit from 
discussing and evaluating different APPE structures and learn from 
each other. A description of the APPE at the University of Oslo 
(UiO) is given elsewhere, but evaluation is focused on here.  
Purpose 
To analyse stakeholder views regarding the APPE period: the views 
of the supervisors in pharmacies and the student perspective.  
Methods 
Two series of qualitative in-depth interviews, with 9 supervisors in 
January 2017 and with 7 pharmacy students in 
November/December 2017. The interviews were transcribed 
verbatim and analysed with the Systematic Text Condensation 
approach.  
Results 
Mandatory assignments were described as challenging and time-
consuming. The supervisors considered a solid pharmaceutical 
knowledge to create the basis for evaluating prescriptions and 
making pharmaceutical decisions and saw the pharmacist’s role as 
being simultaneously problem solvers and using pharmaceutical 
judgment. The students expected to apply their theoretical 
knowledge in practice setting and get good training in the roles 
expected of a professional pharmacist, and described the 
supervisor and location of the internship pharmacy as major 
determinants of the outcome of the internship. The supervisors 
considered the students to use much time on technical issues, and 
to be uncertain at the end of the APPE while still seeing 6 months 
as sufficient.  
Conclusions 
Expectations of students, supervisors and university need 
alignment. Standardisation and continuing education for 
supervisors is needed. 
 
 
Poster031 
 
Adherence to and preferences for vitamin D in 
different pharmaceutical forms and administration 
frequencies – a study design 
 
Jean-Pierre ROTHEN, Jonas RUTISHAUSER, Philipp 
WALTER, Kurt E. HERSBERGER, Isabelle ARNET 
Background 
The importance of vitamin D supplementation, particularly during 
winter, is increasingly recognised in Europe. Most supplements in 
Switzerland are oily or alcoholic liquids intended for daily 
administration. Although intermittent, weekly and monthly, 
administration has demonstrated equal efficacy, patients’ 
preference and adherence have rarely been studied.  
Purpose 
To assess adherence to and preference for vitamin D in different 
pharmaceutical dosage forms and frequencies of administration in 
outpatients. 
Methods 
Experts, health professionals and patients, discussed during a focus 
group, which pharmaceutical form and which administration 
frequency of oral vitamin D supplementation would lead to the 
best adherence at different ages of life. Power calculation showed 
that 59 patients per group will be sufficient to detect a difference 
of 25% in timing adherence with a 80% power.  
Results 
Study design: Interventional, randomized, cross-over study with 8 
general practitioners in Switzerland. Patients obtain vitamin D 
supplements either as tablets (5600 IU) and capsules (20’000 IU) or 
oily (5600 IU) and alcoholic drops (24’000 IU), for weekly and 
monthly administration over 3 months, respectively. Blood 
samples and questionnaires are obtained at inclusion, 3 and 6 
months. Adherence is monitored electronically, for the solid forms 
with POEMS technology, and for the liquid forms with Time4Med 
smart cards. Patients ≥18 years old with vitamin D level <50 nmol/l 
at baseline, taking at least one oral medication are recruited. 
Patients with hypercalcemia or nephrolithiasis are excluded. 
Primary outcome is adherence (taking and timing). Secondary 
outcomes are preferences and improvement of vitamin D levels. 
Conclusions 
This study will provide information on patients’ preference and its 
influence on adherence to vitamin D supplementation, comparing 
liquid and solid forms under two types of intermittent 
administration." 
 
 
Poster034 
 
What are the experiences of clinical pharmacists in 
general practice starting and integrating into their 
role? 
 
Kathryn ELLIS 
Background 
As outlined in NHS England’s 2017 General Practice Forward View, 
there are plans to provide a pharmacist in general practice per 
30,000 of the population by 2020/2021 following the pilot scheme 
launched in 2015. There is limited research into this role in the UK, 
but integration of clinical pharmacists has been studied more 
extensively in other countries.  
Purpose  
The aim of this research was to look at the experience of clinical 
pharmacists starting their role and integrating into general 
practice, based on self-perceptions of the quality and range of 
their induction and their relationships within the team. The 
objectives were to understand the themes of induction, 
relationships, role identification/development, mentoring, and 
training and development and how these impact clinical 
pharmacists starting their role and their integration.  
Methods 
A qualitative methodology involving a total of thirteen semi-
structured telephone interviews were conducted with clinical 
pharmacists from the pilot scheme that met the sampling criteria 
using an iteratively developed interview guide.  Analysis was 
undertaken using the one sheet of paper (OSOP) method by three 
researchers.  
Results  
Analysis revealed five key themes resulting from the interviews; 
induction, relationships, role identification/development, 
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mentoring, and training/development. Two subthemes were also 
identified; induction needs under induction and GP trust under 
relationships. 
Conclusions 
This research documents the varied experiences of pharmacists 
beginning their role and their integration into general practice. The 
key findings have implications in practice for successful integration. 
Induction needs were identified, mentoring had a lack of structure, 
and the importance of relationships was highlighted - particularly 
building GP trust. The role of the clinical pharmacist was found to 
be varied, with a limited common definition enabling flexibility for 
the individuals and the practices. 
 
 
Poster036 
 
Assessing knowledge of community pharmacists on 
cancer: a pilot study in Ghana 
 
Kofi B. MENSAH, Frasia OOSTHUIZEN, Varsha BANGALEE 
Background 
GLOBOCAN estimates that 16,600 cases of cancer occur annually in 
Ghana. Community pharmacists are the first point of contact to the 
public due to their accessibility, wide spread and credibility. They 
provide first aid, treatment of common illness, health information, 
etc. Their roles expand beyond patients to their circle of family and 
friends. The facts that they provide should be correct and help in 
building awareness.  
Purpose 
The goal of this pilot study was; (1) to collect a preliminary data on 
community pharmacists’ knowledge, risk factors, signs and 
symptoms of cancer, (2) ascertain the adequacy of the research 
survey in determining their level of knowledge, (3) To assess the 
visibility of a full scale study. 
Methods 
A cross-sectional study was conducted using a self-administered 
questionnaire to assess the knowledge, signs and symptoms, risk 
factors on cancer among 150 community pharmacists. 
Results 
Score for knowledge on cancer among community pharmacists 
indicated that 84% had poor knowledge. Their responses towards a 
list of warning signs and symptom of cancer indicated poor level of 
knowledge (70%). Community pharmacists recorded poor level of 
knowledge (62%) on causes and risk factors for cancer. Gender, 
age and years of practice had a relationship on the scores 
obtained. 
Conclusions 
This pilot study provided a valuable data which indicated that 
community pharmacists in Ghana have poor level of knowledge on 
cancer. The findings obtained from the study agree with findings of 
other studies conducted in this area which suggest that survey 
instrument was adequate to assess the knowledge level of 
community pharmacist in Ghana. Again response indicated a 
visibility of conducting a full scale research in this workforce to get 
a better assessment of the level of knowledge of community 
pharmacists on cancer in Ghana. 
 
 
Poster038 
 
Pharmaceutical care services for promoting the 
rational use of clopidogrel in coronary syndromes 
 
Luana J. CAMPOS, Fernanda S. TONIN, Flávia R. ARROTEIA, 
Orli D. BOEIRA, Ildemar M. CANTO, Carlos J. SIGNORINI, 
Ana F. OLIOTA, Andréia C. SANCHES 
Background 
Acute Coronary Syndrome (ACS) is the major cause of mortality 
worldwide. Dual antiplatelet therapy (DAPT) with 
Clopidogrel/Acetylsalicylic Acid (12 months regimen) is the main 
prevention therapy for atherothrombotic events in patients with 
ACS. However, in clinical practice drug treatment is usually 
maintained for a considerably longer than recommended. This lead 
to an increase risk of adverse effects and excessive costs.  
Purpose 
The aim of our study was to promote the rational use of 
Clopidogrel in ACS patients through pharmaceutical care services 
in the city of Cascavel-Parana/Brazil. Patients with ACS were 
followed between November/2017 and April/2018.  
Methods 
The population of the study was composed by n=100 patients 
using Clopidogrel for ACS. Of these, 12% used Clopidogrel alone 
and 37% were on DAPT within the established time. However, 
around half of the patients (51%) used DAPT in disagreement with 
the clinical guidelines and reported the appearance of bruising or 
some type of bleeding. For these patients, pharmacotherapeutic 
orientations were performed, and a letter was sent to prescribers 
requesting a reassessment of the therapy by the cardiologist.  
Results 
Of these, 59% (30/51 patients) had their drug therapy re-adapted, 
as recommended by clinical protocols, with the suspension of 
Clopidogrel.  In 41% of the cases (21/51 patients) a medical 
justification was presented for the continuation of the treatment.  
Conclusions 
The written pharmaceutical intervention (letter to prescribers) is 
an instrument that can significantly contribute to the promotion of 
the rational use of medicines, generate savings for the health 
system and improve the quality of life in patients. 
 
 
Poster039 
 
Pharmacy-practice research: opinions and 
perspectives from researchers to a pharmacy R&D 
unit 
 
Luís LOURENÇO, Marta LOPES, Lígia REIS 
Background 
Following the experience running research studies, a community 
pharmacy located in Lisbon district created a Research & 
Development (R&D) Unit. 
Purpose 
To collect the opinions and perspectives of health and non-health 
researchers concerning “community pharmacy” participation in 
research studies. 
Poster Presentations. Pharmacy Practice 2018 Jun;16(Suppl1):1340.  
https://doi.org/10.18549/PharmPract.2018.s1.1340 
www.pharmacypractice.org (eISSN: 1886-3655 ISSN: 1885-642X) 11 
Methods 
Exploratory study based on a survey to researchers from different 
scientific fields. The study initiated in April 2018 and it is still 
running. A convenience sample was used. 
Results 
Opinions and perspectives of 45 researchers, 23 (51.1%) 
Portuguese and 22 (48.9%) from other countries were collected, 
mainly from health sector (64.4%) and pharmacists (89.6%). Most 
researchers show agreement to the statements related to the 
proposed “attitudes towards research” and “barriers to research 
participation”. The degree of agreement was not so marked on the 
“recognition of the purpose of research” (31.1% some 
disagreement), the fact that the “pharmacist does not have time to 
research” (40% some disagreement) and the “lack of skills to 
investigate” (26.7% some disagreement). 86,7% mention that 
research studies in community pharmacy should be based in 
collaboration protocols, 75,6% that pharmacies should be 
organized in a network in order to run studies and 73,5% that 
there must be a body that certifies pharmacies in the context of 
research. The model in which “research projects are designed by 
institutional partners and the pharmacy carries out the project” 
(model 2) and the one in which “ the initiative of the research 
project is from the pharmacy but supported by the university” 
(model 3) were preferred. 82.2% showed interest in collaborating 
with the R&D Unit. 
Conclusions 
It is recognized the need to develop research studies in the 
community pharmacy practice, both in professional and business 
related areas. Researchers are open to collaborate in the proposed 
initiative. 
 
 
Poster040 
 
The Most frequently used facilitation strategies 
during the implementation of innovations in 
healthcare practice: a systematic review 
 
Lydia MOUSSA, Shalom I. BENRIMOJ, Victoria GARCIA-
CARDENAS 
Background 
To improve patient outcomes, healthcare practices undergo 
constant implementation of innovations. Implementation is a 
complex process that takes into consideration organisational, 
behavioural and climate aspects. An implementation intervention 
that considers these aspects is facilitation. Facilitators help 
implement innovations by; highlighting the need for change, 
identifying areas of development, educating members, promoting 
quality improvement while providing support. Whilst the role of 
facilitators is highlighted in the literature, research shows only 5-
30% of trials of behavioural change are described in sufficient 
detail, making it difficult to provide consistent delivery, determine 
fidelity and undergo adequate evaluation. 
Purpose 
The main aim of this paper was to summarise the evidence on the 
effectiveness of strategies used by facilitators during the 
implementation of innovations in health care.  
Methods 
A systematic review was undertaken. Randomised controlled trials 
including an onsite facilitator facilitating the implementation of an 
innovation in a healthcare setting were identified through 
PubMed, SCOPUS and Web of Science. Qualitative data was then 
extracted and categorised according to the following categories: 1) 
Planning for change 2) Leading/ managing change 3) Monitoring 
progress 4) Evaluating change.  
Results 
The database search yielded 2,350 articles, which were screened 
and 35 studies were included. From these, 66 facilitation strategies 
were identified. Twelve of the strategies were used in more than 
25% of the studies - these included; Baseline audit and feedback, 
goal setting, identification of an internal champion, tailoring the 
facilitation approach and providing training. The different 
combinations of the most common strategies were further 
compared regarding their effectiveness.  
Conclusions 
These findings provide facilitators with evidence-based strategies 
outlined in a structured facilitation process, while providing 
researchers, organisations and implementation teams a starting 
point for training, planning and evaluating facilitation interventions 
in healthcare practice. 
 
 
Poster041 
 
Drug administration adjustments for elderly 
patients with dysphagia 
 
Marcela FORGERINI, Patrícia C. MASTROIANNI 
Background 
Dysphagia is a common clinical manifestation among the elderly 
and it is an important symptom in dementia. It has been estimated 
that up to 45% of patients with dementia have some degree of 
swallowing difficulties. Furthermore, dysphagia can negatively 
affect patient’s medication use, thereby influencing decisions 
about patient prescription, which consequently influences 
pharmacotherapy effectiveness and safety.  
Purpose 
Therefore, it was proposed to identify and evaluate the 
pharmacotherapeutic effectiveness and safety of patients with 
diagnosis of Alzheimer's disease and dysphagia .  
Methods 
An experimental, non-randomized study was conducted at the 
Elderly Reference Center of Araraquara with patients with a 
probable diagnosis of Alzheimer's disease. It was leading to 
Medication Therapy Management (MTM) according to the 
Pharmacotherapy Workup, method that collaborated to evaluate 
Medication Use Problems.   
Results 
Female elderly patient, 76 years, diagnosed with depression, 
hypothyroidism, Alzheimer’s disease, mild cognitive deficit and 
moderate dysphagia (Score 4, Scale ASHA-NOMS) was identified 
with sertraline, and levothyroxine related problems. In addition, 
the patient was presenting apathy, fatigue, agitation, 
aggressiveness and hallucination. The MTM was used to adjust 
therapy to the patient’s needs by macerating sertraline tablets and 
solubilizing them in 10-30 mL of orange juice. Patient was advised 
to take levothyroxine following fasting. Six months later, 
pharmaceutical follow-up identified an increase in the Mini-Mental 
Scale score from 22 to 26 and Clinical Dementia Rating (CDR) from 
1.0 to 0.5 in conjunction with mood and physical improvements as 
well as a significant decrease in aggressiveness and agitation.  
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Conclusions 
Cognitive deficit may be a result of drug therapy poor drug 
administration procedures, leading to drug ineffectiveness. 
Optimizing levothyroxine and sertraline administration, with 
knowledge of their physicochemical properties, improves their 
clinical effectiveness, including the cognition of the patient with 
Alzheimer's disease and dysphagia. 
 
 
Poster042 
 
Safety assessment of omeprazole use: a systematic 
review 
 
Marcela FORGERINI, Stephania MIELI, Patrícia C. 
MASTROIANNI 
Background 
Proton pump inhibitors (PPIs), such as omeprazole, are one of the 
most widely prescribed classes at worldwide. However, there are 
studies reporting the risks of hospital admission for adverse drug 
reactions and drug interactions related to the use of omeprazole. 
In addition, the safety of a drug can be modified over time due to 
increased use and patient characteristics, and risk assessment is 
required.  
Purpose  
Therefore, the guiding question sought what are adverse events 
and how effective omeprazole treatment is, 
Methods 
Propose to evaluate the safety of the use of omeprazole and a 
Systematic review of studies was conducted.  PubMed, SCOPUS, 
LILACS, SciELO, EMBASE and EBSCO databases were searched 
through September/2016. Clinical, cohort, and case-control trials, 
cross-sectional and quasi-experimental studies, which reported 
outcomes ineffectiveness and/or safety about omeprazole use, 
were screened. The risk of bias of the different outcomes were 
assessed. 62 articles were included.  
Results 
50 studies reported adverse drug events [39 adverse drug reaction, 
five drug interactions, six ineffectiveness]. 14 adverse drug 
reaction are not described in the literature: spontaneous 
abortion(1); proliferative changes(1); chills(1); myocardial 
infarction(6); heart failure leading(1); stroke(2), thrombosis(2); 
eczematous eruption(1); among others. Severe adverse reaction 
occurred in patients who underwent heart-related surgeries or 
drug interventions, or in the concomitant use of such medications, 
with inhibition of the antiplatelet effects of drugs such as 
clopidogrel, increasing the risk of developing cardiac problems and 
decreased absorption of mycophenolate mofetil, leading to 
rejection of transplanted organs. All indications for the use of 
omeprazole were approved, therefore, there was no evidence of 
safety of omeprazole use in polymedicated patients.  
Conclusions 
The use of omeprazole should be monitored primarily in patients 
with heart disorders using antiplatelet agents concomitantly and in 
newly transplanted patients using mycophenolic acid, in order to 
avoid serious adverse reactions. 
 
Poster044 
 
Pharma-care management in medicine efficacy and 
risk. Spanish community pharmacy 
 
Amparo PEREZ BENAJAS, Virginia MERINO SANJUAN 
Background 
Farmacia del Mercat is in an historical and touristic area located 
200 meters from the Central Market in the city of Valencia, Spain. 
It is an antique pharmacy with only 30 square meters of public 
attention zone. In 2017, we did a request about the origin of the 
pharmacy clients: 40 % were neighborhood clients, 30 % worked in 
companies near the pharmacy, 10% were tourist and 20 % people 
who went to buy at Central Market. 
In our pharmacy, focusing on the third dimension FIP-OMS 
guidelines , we define pharma-care process as the patient 
experience of assuring the effectiveness, preventing harm from 
medicines and making responsible use of limited health care 
resources. This process involves 6 services: 
1. Patient file in which all the medicines, bio measures and health 
issues are compiled. 
2. Telephone message in prescription activations 
3. Ready patient trade mark preference  
4. 4 delivery services a day and information about medicines 
market provision 
5. Special awareness in first prescription, complex medicines and 
pediatric doses 
6. Security alerts on AGEMED notes and patient medicines 
interactions 
We apply PDSA method to improve over the counter pharma-care 
process in order to accomplish patient needs and expectations in 
therapy management. 
Purpose 
By June 2018, 60% of the pharmacy clients have a patient file that 
provides effective medication therapy management by the 
pharmacist. 
Actions taken 
2017, First term 
Define the system according with Eduard Deming Knowledge 
theory. (figure 1) 
Define pharma-care aim statement and quality outcomes 
Define over the counter work-flow including pharma-care services 
(figure 2) 
Define pharma-care services with 13 words in order to facilitate 
the communication between technicians, pharmacist and patients. 
2017 Second term 
Improve managing patient medication therapy according with the 
origin of clients. 
2018 First term 
Ja. Define pharma-care services according FIP-OMS framework 
(figure 3) 
Fe. Re-define drivers diagram, outcomes and improvements 
needed (figure 4,5) 
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March-May . Stablish weekly clinical pharma-care sessions with all 
the workforce to improve the information given to patients, both 
medicines and health status over the counter pharma-care services 
( figure 6) 
Results 
By September 2017, 25% clients have patient file. This number 
increases to 50% in March 2018" 
 
 
Poster045 
 
The impact of pharmacist recommendations on the 
health care team 
 
Livia R. ROCHA, Eliza M. MOURA, Maria G. LEOPARDI-
GONÇALVES 
Background 
The prior knowledge of this acceptance has been very lacunar at 
national and regional levels. In the ambience like a teaching 
hospital was an endpoint (outcome) of 4 years implantation of 
clinical pharmacy services by pharmacy residents. 
Purpose 
This work constitutes an effort aiming to an account of a real and 
effective knowledge of the impact of the clinical pharmacist 
recommendations on the attitudes and procedures of the health 
care team. 
Methods 
It was a retrospective and descriptive study. We study the clinical 
interventions performed by pharmacy residents in their 
professional routine during the period from Nov 2010 and Mar 
2015 and registered on patient’s pharmaceutical record.  The 
studied variables were the following: (1) the intervention 
acceptance; (2) the intervention type; (3) the drug related problem 
(DRP) which pharmacist’s intervention attempted to prevent or 
resolve; (4) to whom it was directed, whether physician, nurse, or 
another member of the health care team; and (5) the form of 
intervention, whether verbal and/or written.    
The criteria adopted by us in order to consider a given procedure 
as accepted one was the modification and implantation of the 
pharmacist recommendation by the recipient professional in a 
period equal to or minor than 24 hours. 
Results 
The more relevant results were: (a) the interventions performed 
were 316, which 277 (88%) were accepted. 
(b) It was found 248 patient’s pharmaceutical records; among 
these 137 (55%) presented at least one pharmaceutical 
intervention. 
(c) the most frequent performed intervention type was related to 
the therapy optimization (33%) followed by optimization of 
administration conditions (22%); 
(d) 90% among the interventions were in verbal form. 
Conclusions 
These results show that the clinical pharmacist recommendations 
were successful and therefore have a strong impact on attitudes 
and procedures of the health care team. 
 
 
Poster047 
 
Technology-enabled pharmacy: analysing the 
relationship between pharmacy practice and health 
technologies in community pharmacy 
 
Mohammad ALKANDERI, Darrin BAINES, Stephen TEE, 
Carol BOND 
Background 
This work is important because changes in technology are creating 
new opportunities for pharmacy practice. It fills the gap because 
we currently have limited understanding of the relationship 
between pharmacy practice activities and technology. The context 
of the research is that new health technologies are creating new 
opportunities to improve pharmacy practice. 
Purpose 
The purpose of this research is to use the WHO classification of 
Digital Health Interventions (v1.0) and to show the link between 
type of initiative services and technologies.  
The hypothesis of this research is that different types of 
technologies could support different types of pharmacy practice 
activities.  
Methods 
We have created a conceptual framework using documentary 
analysis that links the WHO classification system with pharmacy 
practice activities and key health technologies.  
Results 
The proposed outcome is a usable framework that supports and 
promotes the linkages between pharmacy practice activities and 
new technologies. 
 
 
Poster048 
 
Developing a leadership attributes development 
tool for pharmacists 
 
Nadia BUKHARI, Ian BATES 
Background 
It is widely accepted how crucial it is to understand the 
development of leadership attributes of practitioners, alongside 
the essential infrastructure and support mechanisms for the 
development of leadership across all stages of the pharmacy 
workforce.     The development of appropriate education and 
training strategies and plans targeted to developing these 
leadership attributes will then result in a workforce better able to 
deliver the evolving health service needs.  
This aligns with the WHO statement “No health without a health 
workforce"",2013 (1)  which acknowledges that the delivery of 
better health requires a workforce that constantly develops and 
grows. 
FiP Workforce Development Goals: 
FiP have built a sustainable near and longer term plan of action on 
the range and scope of pharmaceutical workforce development 
goals, which is a global vision for Pharmacy Education and the 
workforce.(3)   
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Leadership training and development can maximize productivity 
and shape a positive culture.  WDG-6 focuses on strategies and 
programmes that need to be in place to support the development 
of professional leadership skills for all stages of career 
development, including pharmaceutical sciences and initial 
education and training. 
To achieve this, we must understand leadership in more detail and 
therefore more research around leadership in pharmacy is needed.  
Purpose 
The aim of the study is to develop a leadership attributes 
development tool for pharmacists (LADT) 
The objectives for the study are as follows: 
1. To investigate how pharmacists, perceive their own leadership 
attributes 
2. To conduct a review of the delivery of current leadership 
attribute development for pharmacists  
3. To evaluate how leadership outcomes are recognised amongst 
the professional body 
4. To evaluate the leadership attribute development tool for 
pharmacists 
Methods 
The design of the study is outlined in fig.1. Both quantitative 
(questionnaires) and qualitative (semi-structured interviews) 
methods will be used to investigate leadership concepts and 
perceptions within the pharmacy profession.  The results from 
both the methods used will inform the development of the LADT. 
Conclusion                            
Leadership and the development and impact of leadership is under 
researched in the UK; in particular pharmacy leadership.  This 
trend has also been explored globally via the literature review.   
Leadership has become a focus for healthcare provision in the UK 
post Francis. The Royal Pharmaceutical Society launched the 
pharmacy adaptation of the NHS Leadership Development 
Framework in 2015, reinforcing the fact that this is an optimum 
time to conduct this evaluation of leadership development within 
pharmacy. 
 
 
Poster050 
 
INDICA+PRO: Study of a minor ailment service in 
community pharmacy in a Spanish province. 
Preliminary data, referral rates 
 
Noelia AMADOR-FERNÁNDEZ, Victoria GARCÍA-
CÁRDENAS, O GARCÍA-AGUDO, Vicente J. BAIXAULI-
FERNÁNDEZ, Vicente COLOMER-MOLINA, Maria T. 
CLIMENT-CATALÁ, Miguel A. GASTELURRUTIA, Shalom I. 
BENRIMOJ, Fernando MARTÍNEZ-MARTÍNEZ 
Background  
Consultation of minor ailments and direct product request are 
frequent in Community Pharmacy in Spain although every 
pharmacy offers the service following their own criteria. Following 
Standard Operational Procedures (SOP) and referral criteria agreed 
between community pharmacists (CP) and general practitioners 
(GP) is needed to deliver a safer service in Community Pharmacy. 
Purpose 
The aim was to evaluate referral to other health professionals of a 
Minor Ailment Service (MAS, service offered in Community 
Pharmacy following the SOP) compared to usual care in the 
province of Valencia (Spain). 
Methods 
Randomized controlled study with 2different groups is been 
carried out for 6months, winter and spring. 
The intervention has different components: 
- SOP: Focus group consisting of 4GP and 4CP. 
- Formulary and list of ailments (headache, sore throat, 
dysmenorrhea, cold, nasal congestion, cough, heartburn, diarrhea, 
vomit, gas, cold-sore and athlete foot). 
- Standard procedure for the consultation. 
- Educational training for pharmacists. 
Preliminary data of the first 4months of the study (winter, 
15/Nov/17-15/Mar/18) are presented. 
Results 
A total of 535patients were recruited in the participant pharmacies 
during the study period. Consultation of minor ailment had higher 
rate (70,7%) than direct product request(29,3%). The 2minor 
ailments causing higher number of consultations were cold (39,6%)   
and cough(23,6%), similarly in both groups. 2,8% (n=8) of the 
patients in the control group were referred to the GP, 2,1% 
following referral criteria included in the agreed SOP, only 
2patients followed CP’s intervention. 6,8% (n=17) of the patients in 
the intervention group were referred to the GP out of 9,1% of the 
patients in the same group having referral criteria due to refusal 
from the patient or pharmacist’s decision, 8patients followed 
pharmacist’s intervention. 
Conclusions  
The MAS has the potential to increase the security in the 
management of minor ailments and the acceptance of the 
pharmacists’ intervention in Community Pharmacy. These 
preliminary results should be confirmed once the study is finished. 
 
 
Poster051 
 
Attitudes of Croatian community pharmacists 
toward adverse drug reaction reporting 
 
Živka Juričić, Renata J. Grubešić, Jadranka V. Rodríguez 
Background 
Adverse drug reactions (ADRs) are a major public health problem 
and must be reported in writing to the official authority. Very little 
is known about community pharmacist’s knowledge, practice and 
attitudes toward ADRs reporting process in Croatia.  
Purpose 
This study aimed to provide a description of the attitude and 
behaviour of Croatian community pharmacists toward the 
reporting of ADRs.  
Methods 
A cross-sectional survey of 100 community pharmacists was 
conducted in Zagreb, Croatia, during two months. The structured, 
validated questionnaire comprised 15 questions to identify 
understanding, views, and attitudes of participant pharmacists 
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toward ADRs, including legal aspects and regulatory framework, as 
well as opinions on their professional obligations and motivation 
for further informing on ADRs.  
Results 
Community pharmacists understand the reporting of ADRs as an 
integral part of their professional duties and they did not report 
any major obstacles to ADRs reporting. Most pharmacists (74%) 
state that the lacking of feedback of the ADRs reports processing is 
a barrier to pharmacist’s further ADRs reporting. About half of the 
pharmacists (54%) think that the reporting procedure is time-
consuming and a reporting form is complex, while 37% of 
pharmacists are not satisfied with the existing rewarding system 
for their ADRs reporting. The pharmacists consider that 
collaboration with physicians before submitting a report is an 
important aspect in the reporting process. The results demonstrate 
that community pharmacists in Croatia have an important role in 
ADRs reporting system. Also, they are knowledgeable and highly 
motivated to do this task.  
Conclusions 
Although 3486 ADRs were reported to the Croatian national 
regulatory agency in 2016, of which 36.1% were reported by 
community pharmacists, our results highlight a need to improve 
technical and rewarding aspects of the ADRs reporting system in 
Croatia. 
 
 
Poster052 
 
Mobile health intervention to support self-
management: pharmacists’ and patients’ 
perceptions 
 
Richelle KOSSE, Marcel L. BOUVY, Tjalling DE VRIES,  
Ellen S. KOSTER 
Background 
The Adolescent Adherence Patient Tool (ADAPT), an interactive 
mobile health (mHealth) intervention for asthma patients, has 
been shown to increase inhaled corticosteroid adherence in 
adolescents with suboptimal baseline adherence. However, the 
implementation and integration of mHealth interventions in 
clinical practice is a complex problem, and evaluations are 
therefore of utmost importance for further implementation. 
Purpose 
To explore experiences, barriers, and facilitators of both 
pharmacists and patients towards the use of the ADAPT 
intervention. 
Methods 
Pharmacists and patients had six months access to the ADAPT 
intervention. We conducted semi-structured interviews with 23 
pharmacists, and 82 patients completed an online evaluation 
questionnaire about the ADAPT intervention. Descriptive statistics 
were calculated. 
Results 
The majority of patients (66%; n=54) did not use the ADAPT 
intervention for the complete six months, with forgetfulness as the 
main reason. Most patients (78%; n=64) would recommend the 
ADAPT intervention to others, and thought the pharmacy was the 
right place for mHealth aiming at improving appropriate use of 
medicines (63%; n=52). The possibility to monitor asthma 
symptoms was the most frequently used functionality of the 
intervention, and highly appreciated by both patients and 
pharmacists. Almost all pharmacists (96%; n=22) were satisfied 
with ADAPT, and the use of the intervention was not time 
consuming for most (91%; n=21). Pharmacists thought that the 
ADAPT intervention promoted contact with patients (74%; n=17) 
and that it facilitated their role as a healthcare provider (83%; 
n=19). Technical problems were experienced by 30% of the 
pharmacists (n=7) and by 28% of the patients (n=23). 
Conclusions 
Pharmacists and patients perceive many beneficial effects, and 
were generally positive about the interactive mHealth 
intervention. Attention should be paid to prevent technical issues. 
These findings should be taken into account, and mHealth 
opportunities may be emphasized among pharmacists. 
 
 
Poster053 
 
Management of drug-drug interaction alerts in 
German community pharmacies 
 
Ronja WOLTERSDORF, Christina A. BRAUN, Sven SIMONS, 
Ulrich JAEHDE 
Background 
Potential drug-drug interactions (DDI) are described as the drug-
related problem most frequently detected in German community 
pharmacies. However, little is known about the actions taken by 
pharmacists following DDI alerts. 
Purpose 
Our aim is to evaluate the DDI management in community 
pharmacies in order to generate strategies to improve its quality 
and to facilitate assessing the relevance of individual DDI alerts. 
Methods 
In cooperation with the “LINDA-Apotheken” network of 1.100 
German community pharmacies we developed a recording system 
to automatically generate datasets of all detected DDI alerts by the 
pharmacy software. Beside statistical analysis of the frequency of 
specific alerts these datasets formed the basis for the development 
of a standardized electronic documentation form that allows for 
collection and evaluation of actions performed in community 
pharmacies in daily routine. 
Results 
Preliminary results highlighted the high and variable frequency of 
more than 194.500 DDI alerts (1.532 (218 – 4.656) per pharmacy) 
detected in a pilot study in 127 participating pharmacies within 
one month. 10 specific combinations reflected 57% of DDI alerts 
classified as potentially severe (2.9% of all DDI alerts) with 
potential outcomes including prolongation of the QT interval, 
hyperkalaemia, hypertensive crisis, agranulocytosis, serotonin 
syndrome and bleeding. In future, additional information on 
required actions following DDI alerts will be obtained by rollout of 
the documentation form and implementation in routine processes. 
Moreover, changes in DDI management after providing additional 
teaching material and increasing the awareness of frequent DDI 
alerts by informing the individual pharmacies on their own 
performance statistics will be evaluated. 
Conclusions 
In conclusion, the generated dataset on DDI management will 
provide a broad basis for documentation of the performance of 
German community pharmacies in managing DDI alerts in general 
as well as for assuring and improving its quality at the individual 
pharmacy level. 
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Poster055 
 
Bringing health promotion and education to schools 
– impact and evaluation of the healthy generation 
project 
 
Ema PAULINO, Sara TORGAL, Teresa COUTO, Diana COSTA 
Background 
Geração Saudável (Healthy Generation) is a public health 
promotion and health education project led by the Portuguese 
Pharmaceutical Society, targeted to school age children. 
Purpose 
Evaluate the project’s general impact, through direct assessment 
of students’ knowledge on the addressed topics and the number of 
students and schools covered. 
Methods  
The Project promoted training on diabetes, responsible use of 
medicines and drug abuse to children with an average age of 11.61 
old. Trainings were held in an especially adapted bus, addressing 
also the promotion of the pharmacists’ role in society. 
(1) To evaluate the training, students were randomly 
selected to answer a questionnaire on the topics covered, 
composed of 9 multiple choice questions, with only one correct 
answer out of four. By the end of the school year, a descriptive 
analysis was conducted to characterise the different variables, 
according to the main variable: with/without training. 
(2) The number of schools and students’ covered was 
also analysed, by comparison with the previous school year. 
Results 
1136 students participated, from which 52.4% (n=594) had already 
received training. The average number of correct answers was 
higher in the group that had already received training (7.73 in 9) in 
comparison to the other group (5.25 in 9). By the end of the school 
year 2016/2017, the Project had visited 68 schools, covering 
12,183 students (+523 [4.49%] when compared with 2014/2015) 
and 648 teachers (+34 [5.54%]). 
Conclusions 
Training sessions had a positive impact on students’ answers, who 
showed a better knowledge on the topics. In addition, comparing 
with the school year 2014/2015, the number of schools, students 
and teachers increased significantly. 
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Needs of advanced and specialist practice from 
Indonesian pharmacists’ perspectives: an 
implementation of FIP Workforce Development goal 
number 4 
 
Sherly MEILIANTI, Ian BATES 
Background 
Many countries are developing a focus on the advancement of 
pharmacy practice in order to provide impactful services to face 
worldwide health challenges. Taking care of more complex 
diseases resulting from ageing population is one of major 
challenges for Indonesia’s health system. Pharmacists as medicines 
expert need to have skills which are more advanced to deal with 
more complex medicines to provide better care and improve 
society’s health. 
Purpose 
This study aims to explore pharmacists’ perceptions related to the 
need of advanced practice development in Indonesia. 
Methods 
This study was conducted by interviewing 43 practising 
pharmacists from September to October 2017. A mixed method of 
data collection including focus group discussions and one-to-one 
interview was conducted based on the availability of participants. 
The interviews were transcribed and analysed thematically using 
the pre-coding frame which was then revised and expanded to 
include new codes emerging from data.  
Results 
An increase of medicines complexity in patients was the reason 
why pharmacists need to be advanced. From the pharmacists’ 
perspectives, the need for a clearer developmental career pathway 
was emphasised by those having less than 5 years’ experience and 
working in patient care settings. As the pharmacists become more 
advanced, they can be an equivalent collaborative partner and a 
reliable source of medicines expertise within healthcare teams. 
Pharmacists across the country perceived that defined advanced 
practice would have positive impact on the society and National 
Health Service delivery; therefore, developing advanced practice 
was aligned with the aim of the professional body and the 
regulator in Indonesia.  
Conclusions 
This study shows there was a need to develop advanced practice 
from Indonesian pharmacists’ perspectives. Further research on 
defining criteria for advanced practice would be the next step. 
These criteria which show clear career pathway can be used as a 
tool for subsequent professional recognition as markers for 
practice advancement. 
 
 
Poster057 
 
A qualitative study of Indonesian pharmacist 
perception on their challenges of practice: Mapping 
to the Pharmaceutical Workforce Development 
Goals 
 
Sherly MEILIANTI, Ian BATES 
Background 
Recently, pharmacists face many challenges due to an increase in 
ageing population. Little is known of pharmacist's perception of 
difficulties that they encounter in the workplace specifically in 
Indonesia. This study aims to explore opinions of pharmacists 
regarding challenges that they face in the workplace in the context 
of professional development. 
Purpose 
This study is part of a bigger project on developing advanced 
practice in Indonesia. A semi-structured interview of purposively 
sampled 24 Indonesian pharmacists was conducted from 
September to October 2017. The interviews were transcribed and 
analysed iteratively using a pre-coding frame which was obtained 
from the 13 Pharmaceutical Workforce Development Goals 
(PWDGs) established by the FIP. The cluster of PWDGs sets as a 
theme and the goals sets as sub-theme. 
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Methods 
The professional development cluster was the most frequent 
cluster mapped. Pharmacists with less than 3 years experiences, 
and working in patient care setting, expressed a need for 
competency development in their workplace. Hospital and 
community pharmacists perceived that crossover between sector 
and “working with others” were barriers in providing services. 
Academy cluster: most pharmacists who practice in community 
setting or university stated that interprofessional education in 
university and early foundation training is essential to prepare 
pharmacists for the workplace. System cluster: workforce impact 
has not been recognized in Indonesia, there are a limited number 
of pharmacists in patient care setting and need for better 
regulation enforcement. Three new themes emerged: challenges 
to pharmacists themselves, in pharmacy organizations and in 
conducting evidenced-based research. Minimum initiative of 
pharmacists became barriers to developing the profession. 
Optimization of pharmacy organization role and evidence-based 
research to support regulation are important for pharmacists to 
support their career. 
Conclusions 
This study shows that establishment of career pathway and 
unpreparedness of pharmacists after graduate challenge 
Indonesian pharmacist the most. Further research on actions to 
deal with these challenges needs to be done. 
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An overview of systematic reviews of economic 
evaluations of pharmacy-based public health 
interventions: addressing methodological challenges 
 
Suzete COSTA, João PEREIRA, Dennis K. HELLING, Céu 
MATEUS 
Background 
The economic evaluation of pharmacy services requires certain 
considerations which differ from the evaluation of medicines. 
Some do not seem to be exclusive to pharmacy, they exist in public 
health interventions. It may also be useful to explore 
recommendations for conducting economic evaluations alongside 
trials. 
Purpose 
To perform an overview of systematic reviews of economic 
evaluations of pharmacy services and triangulate results with 
recommendations for economic evaluations of both public health 
interventions and alongside trials to assist in improving research 
methods.  
Methods 
1) Exploratory review of recommendations on the economic 
evaluation of public health interventions; 2) Exploratory review of 
recommendations for conducting economic evaluations alongside 
clinical or pragmatic trials; 3) Overview of systematic reviews of 
economic evaluations of pharmacy interventions (protocol 
registered, reference no. PROSPERO 2016: CRD42016032768 
(http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CR
D42016032768). 
Results 
Fourteen systematic reviews were included containing 118 
publications corresponding to 75 index publications. Only two 
reviews addressed economic evaluation in community pharmacy 
exclusively. Reviews reported favorable economic findings for 71% 
studies with full economic evaluations or CCA or CMA. Types of 
economic analysis are diverse. The two critical quality domains of 
AMSTAR-2 absent from most reviews are 1) protocol prior to 
review and 2) list of excluded studies. Key methodological findings 
include: certain types of risk of biases; study designs not restricted 
to RCTs; most economic quality criteria met but some issues 
unresolved or unclear: population, comparator, costs, analytical 
methods, incremental costs and outcomes, uncertainty, 
heterogeneity, equity, process and external validity. Triangulation 
revealed additional gaps. 
Conclusions 
A methodological approach for economic evaluation of pharmacy-
based public health interventions was proposed. These findings 
may assist in improving the design of pilot trials of economic 
evaluations in pharmacy, as well as providing evidence for payers. 
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Pharmacist prescribing and care improves 
cardiovascular risk, but what do patients think? A 
sub-study of the RxEACH study 
 
Yazid N. AL HAMARNEH, Sarah LAMB,  Maoliosa DONALD,  
Brenda HEMMELGARN, Kathryn KING-SHIER, Charlotte 
JONES, Cliff MITCHELL, Ross T. TSUYUKI 
Background 
The Alberta Vascular Risk Reduction Community Pharmacy Project: 
RxEACH, was a randomized trial which demonstrated that a 
community pharmacy-based case finding and intervention 
program (including prescribing, laboratory testing, and follow-up) 
reduced the risk for cardiovascular (CV) events by 21% when 
compared to usual care. 
Purpose 
To evaluate patient perceptions regarding pharmacist prescribing 
and care in patients at high risk for CV events. 
Methods 
All participants who took part in RxEACH received an invitation 
letter. Those who took part in the interviews provided verbal 
consent. Participants were asked to provide their opinions about: 
• The care they received from pharmacists 
• Communication between patients, pharmacists and family 
physicians 
• Suggestions for sustainability 
Interviews were recorded and transcribed verbatim. Three 
reviewers (including one patient who did not participate in 
RxEACH) analyzed and coded the data independently.  
Results 
Data saturation was achieved after interviewing 14 participants. 
Half of whom were male and approximately two-thirds were older 
than 60.  The following themes were identified:  
(i) Patient-pharmacist relationship: Participants highlighted the 
importance of having a strong relationship with the pharmacist, 
indicating that could enhance their level of comfort with the 
pharmacist. They also felt that pharmacists truly cared about them 
as people.    
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(ii) Healthcare system characteristics: The majority of the 
participants supported expanded scope of practice and identified it 
as an opportunity to fill healthcare gaps highlighting easy 
accessibility, high quality and timeliness of pharmacist services. 
(iii) Patient reaction: Participants were extremely satisfied with the 
care they received and reported that they felt empowered when 
pharmacists encouraged them to take responsibility for their own 
health. 
Conclusion 
Patients are highly supportive of an advanced scope of pharmacy 
practice which includes prescribing, follow-up, and remunerated 
care. Our inclusion of a patient in the analyses provided a unique 
perspective. 
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Cost-effectiveness of pharmacist care for managing 
patients at high risk for cardiovascular disease in 
Canada 
 
Yazid N. AL HAMARNEH, Karissa JOHNSTON, Carlo 
MARRA, Ross T. TSUYUKI 
Background 
The RxEACH randomized trial demonstrated that community 
pharmacist prescribing and care reduced the risk for cardiovascular 
(CV) events by 21%, compared to usual care. 
Purpose 
To evaluate the economic impact of pharmacist prescribing and 
care for CV risk reduction in a Canadian setting. 
Methods 
A Markov cost-effectiveness model was developed to extrapolate 
potential differences in long-term CV outcomes, using different risk 
assessment equations. The mean change in CV risk for the two 
groups of RxEACH was extrapolated over 30 years, with costs and 
health outcomes discounted at 1.5% per year. The model 
incorporated health outcomes, costs and quality of life to estimate 
overall cost-effectiveness. It was assumed that the intervention 
would be 50% effective after ten years. Individual-level results 
were scaled up to population level based on published statistics 
(29.2% of Canadian adults are at high risk for CV events). Costs 
considered included direct medical costs as well as the costs 
associated with implementing the pharmacist intervention. 
Uncertainty was explored via probabilistic sensitivity analysis.  
Results 
It is estimated that the Canadian healthcare system will save $4.6 
billion over 30 years, if the pharmacist intervention was delivered 
to 15% of the eligible population. Pharmacist care would be 
associated with a gain of 592,049 Quality Adjusted Life Years and 
avoid more than 9 million CV events. The intervention is 
economically dominant, i.e. it is both more effective and reduces 
costs when compared to usual care. 
Conclusions 
Across a range of one-way and probabilistic sensitivity analyses of 
key parameters and assumptions, pharmacist prescribing and care 
is both more effective and cost-saving compared to usual care. 
Canadians need, and deserve such care. 
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A survey exploring attitudes, opinions and 
knowledge of emergency contraception among 
pharmacists and pharmacy students 
 
Jadranka V. RODRÍGUEZ, Živka JURIČIĆ, Renata J. 
GRUBEŠIĆ, Mateja BAINAC, Ana BREZOVIĆ 
Background 
Over-the-counter dispensing (OTC) of emergency hormonal 
contraception (EHC) involves several ethical dilemmas, which are 
difficult to address because they involve scientific knowledge but 
also moral and religious dimensions as well as the pharmacist's 
worldview. 
Purpose 
Because of the complexity and specificity of this issue, this study 
aimed to provide the description of the knowledge, attitudes, and 
practices of Croatian community pharmacists toward emergency 
contraception.  
Methods 
A cross-sectional study was conducted among 209 community 
pharmacists in Zagreb area, Croatia. A structured questionnaire 
consisted of sociodemographic characteristics, multiple-choice 
specific questions about EHC, and true/false statements to assess 
knowledge in addition to Likert-type scale questions regarding 
attitudes and opinions. Frequency and descriptive statistics were 
calculated for all variables. Quantitative data analysis was 
performed using univariate and bivariate statistics.  
Results  
The results of the descriptive analysis show that the average 
knowledge about EHC among pharmacists is very good (78.9% 
correctly answered questions). More than 90% of pharmacists 
showed the knowledge regarding regulations involved in the EHC 
dispensing. A higher frequency of incorrect answers (25-46%) is 
obtained for questions about indications, contraindications and 
justification of EHC use. Pharmacists' views on whether the non-
prescription status of EHC and its benefits is medically justified are 
divided. About 15% of the participants believe that they are not 
adequately educated and trained for dispensing of EHC. Bivariate 
analysis showed that there is a statistically significant difference in 
attitudes, opinions and knowledge about EHC depending on 
participants' sociodemographic characteristics.  
Conclusion  
Our results highlight the need to provide more continuous 
education opportunities for licensed pharmacists to be able to 
provide informed pharmaceutical care in the area of EHC. 
 
 
